14th International Conference on the Chemistry of Antibiotics and other Bioactive Compounds, 13-16 October 2015, Texas, USA


Steven J. Wittenberger, AbbVie Paharmaceutical Research and Development, USA

Steven J. WittenbergerDr. Steven J. Wittenberger is a Distinguished Research Fellow and Senior Director in Process R&D at AbbVie.  Dr. Wittenberger joined Abbott Laboratories in 1989 following a post-doctoral appointment at The University of Texas Southwestern Medical Center in Dallas where he worked in the group of Professor J. R. Falck.  He earned his doctorate at The University of Wisconsin-Madison under the supervision of Professor Edwin Vedejs in 1988 and received BS in chemistry at The University of Texas-Austin in 1983.   

Dr. Wittenberger has extensive experience in CMC (Chemistry, Manufacturing and Controls) aspects of drug development and particular expertise in the development of synthetic chemistry to enable preparation of API (Active Pharmaceutical Ingredient) for preclinical and clinical use.  While at AbbVie, he has worked in both process chemistry and medicinal chemistry.  Dr. Wittenberger is an author on more than thirty scientific publications and inventor on twenty-two issued US patents.

« Go Back

Organised by




Supporting Journal

Bioorganic & Medicinal Chemistry Letters